ALK

Highly Engaged Employees

ALK, founded in 1923, is a global pharmaceutical leader specializing in allergy immunotherapy and diagnostic solutions. The company focuses on developing, manufacturing, and marketing evidence-based treatments for respiratory allergies, including pollen and dust mite sensitivities. By providing both sublingual and subcutaneous immunotherapy, ALK addresses the underlying causes of allergic conditions rather than merely managing symptoms. Their research-driven approach ensures that healthcare professionals receive high-quality medical guidance and specialized pharmaceutical products to improve patient outcomes worldwide.

Operating with a workforce of 1,000-5,000 employees, ALK maintains a robust international presence across 18 locations. The company’s portfolio includes a diverse range of allergen extracts, tablets, drops, and injection therapies designed for both pediatric and adult populations. These products are central to their mission of disease prevention and long-term allergy management. Through continuous investment in research and development, ALK remains at the forefront of the global allergy care market, ensuring that their therapeutic solutions meet rigorous clinical standards and address the evolving needs of patients across various geographic regions.

ALK’s commitment to innovation is supported by a dedicated organizational structure focused on clinical excellence and corporate responsibility. Meet ALK's team to learn about the leadership driving these advancements in immunotherapy. As a publicly traded entity, the company leverages its century-long history to maintain a competitive edge in the pharmaceutical sector. By integrating sustainability into their corporate strategy, ALK continues to expand its influence in the healthcare industry, providing essential medical support and diagnostic tools that empower individuals to manage their health effectively.